Literature DB >> 8346485

Bone mineral density and body composition in adult patients with cystic fibrosis.

A B Grey1, R W Ames, R D Matthews, I R Reid.   

Abstract

BACKGROUND: Cystic fibrosis is a multisystem disease characterised by chronic pulmonary sepsis and malnutrition. To ascertain whether osteoporosis is a feature of cystic fibrosis in adult patients, total body and regional bone mineral density (BMD) was measured in a group of eight men and eight women aged 17-42 years.
METHODS: Total body and regional BMD (lumbar spine L2-L4, femoral neck, trochanteric, and Ward's triangle), as well as total body fat and lean mass, were measured by dual energy x ray absorptiometry. A range of biochemical, lifestyle, and anthropometric variables was also assessed.
RESULTS: Patients with cystic fibrosis had significantly reduced bone density at all sites compared with normal young adults. The mean reductions ranged from 7% at Ward's triangle to 13% at the trochanter. Body mass index (BMI) was positively correlated with BMD at four sites and disease severity negatively correlated with BMD at two sites. Other biochemical and anthropometric variables were not predictive of bone density. Total body fat mass was reduced by 30% compared with normal young adults.
CONCLUSIONS: Bone density is decreased in adult patients with cystic fibrosis and BMI and disease severity are independent predictors of bone density.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346485      PMCID: PMC464571          DOI: 10.1136/thx.48.6.589

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

1.  Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment.

Authors:  C Landon; R G Rosenfeld
Journal:  Am J Dis Child       Date:  1984-04

2.  Testosterone and bone loss in Klinefelter syndrome.

Authors:  C Foresta; G Ruzza; R Mioni; A Meneghello; C Baccichetti
Journal:  Horm Metab Res       Date:  1983-01       Impact factor: 2.936

3.  Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures.

Authors:  D D Smith; M Gowen; G R Mundy
Journal:  Endocrinology       Date:  1987-06       Impact factor: 4.736

4.  Decreased spinal mineral content in amenorrheic women.

Authors:  C E Cann; M C Martin; H K Genant; R B Jaffe
Journal:  JAMA       Date:  1984-02-03       Impact factor: 56.272

5.  Demineralization in cystic fibrosis detected by direct photon absorptiometry.

Authors:  E H Mischler; P J Chesney; R W Chesney; R B Mazess
Journal:  Am J Dis Child       Date:  1979-06

6.  Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis.

Authors:  K J Desmond; W F Schwenk; E Thomas; P H Beaudry; A L Coates
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

7.  Thromboxane release during percutaneous transluminal coronary angioplasty.

Authors:  M B Peterson; V Machaj; P C Block; I Palacios; D Philbin; W D Watkins
Journal:  Am Heart J       Date:  1986-01       Impact factor: 4.749

8.  Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence.

Authors:  J P Bonjour; G Theintz; B Buchs; D Slosman; R Rizzoli
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

9.  Some biochemical indices of nutrition in treated cystic fibrosis patients.

Authors:  N W Solomons; J B Wagonfeld; C Rieger; R A Jacob; M Bolt; J V Horst; R Rothberg; H Sandstead
Journal:  Am J Clin Nutr       Date:  1981-04       Impact factor: 7.045

10.  Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis.

Authors:  N N Huang; D V Schidlow; T H Szatrowski; J Palmer; L R Laraya-Cuasay; W Yeung; K Hardy; L Quitell; S Fiel
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

View more
  24 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Correlates of prepubertal bone mineral density in cystic fibrosis.

Authors:  R H Haslam; D J Borovnicar; D B Stroud; B J Strauss; J E Bines
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

3.  UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years.

Authors:  Kate A Ward; Rebecca L Ashby; Steven A Roberts; Judith E Adams; M Zulf Mughal
Journal:  Arch Dis Child       Date:  2006-08-30       Impact factor: 3.791

4.  Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.

Authors:  Michael P Boyle; Michelle L Noschese; Sharon L Watts; Marsha E Davis; Shane E Stenner; Noah Lechtzin
Journal:  Am J Respir Crit Care Med       Date:  2005-04-28       Impact factor: 21.405

5.  Sedation with Propofol for Bronchoscopy in Cystic Fibrosis Lung Transplant Recipients.

Authors:  Carrie Ho; Don Hayes; Medhi Khosravi; Mark L Splaingard; Dmitry Tumin; Eric A Lloyd
Journal:  Lung       Date:  2018-05-24       Impact factor: 2.584

6.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

7.  Factors associated with low bone mineral density in patients with cystic fibrosis.

Authors:  Shahid Sheikh; Susan Gemma; Alpa Patel
Journal:  J Bone Miner Metab       Date:  2014-03-16       Impact factor: 2.626

8.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

9.  A prospective study of change in bone mineral density over one year in adults with cystic fibrosis.

Authors:  C S Haworth; P L Selby; A W Horrocks; E B Mawer; J E Adams; A K Webb
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

10.  Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.

Authors:  C M Gordon; E Binello; M S LeBoff; M E Wohl; C J Rosen; A A Colin
Journal:  Osteoporos Int       Date:  2006-03-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.